Puma Biotechnology Inc (PBYI)

Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	26.08%56.50	44.81	75.45	54.48	52.44
Cost Of Revenue	19.68%12.48	10.42	23.13	12.17	12.30
	4.75%17.55	18.42	-	-	-
Selling, General, and Administrative	4.75%17.55	18.42	-	-	-
Costs And Expenses	0.57%48.92	48.64	58.35	44.90	45.80
Depreciation and Amortization	2.63%2.52	2.58	2.66	2.72	2.76
Operating Income/Loss	298.15%7.59	-3.83	17.11	9.57	6.64
Nonoperating Income/Loss	64.59%0.66	0.40	0.00	-0.33	-0.47
Income/Loss From Continuing Operations Before Tax	340.59%8.25	-3.43	17.11	9.24	6.17
Income Tax Expense/Benefit, Current	82.82%0.06	0.33	0.42	0.40	0.31
	318.20%8.19	-3.75	13.44	8.84	5.86
Attributable To Parent	318.20%8.19	-3.75	13.44	8.84	5.86
Basic Average Shares	0.19%50.94	50.85	0.13	50.34	49.70
Diluted Average Shares	3.44%52.60	50.85	0.32	50.93	50.14
Basic Earnings Per Share	328.57%0.16	-0.07	0.27	0.18	0.12
Diluted Earnings Per Share	328.57%0.16	-0.07	0.26	0.17	0.12